Publication | Closed Access
Therapeutic Implications for the Induced Levels of Chk1 in Myc-Expressing Cancer Cells
135
Citations
43
References
2011
Year
Our data suggest that Chk1 inhibitors should be further evaluated as potential drugs against Myc-driven malignancies such as certain B-cell lymphoma/leukemia, neuroblastoma, and some breast and lung cancers.
| Year | Citations | |
|---|---|---|
Page 1
Page 1